Hospital General Naval de Alta Especialidad   Report issue

Government Phase 2 Phase 3 Phase 4
Founded: Mexico City Mexico (1993)

Organization Overview

First Clinical Trial
2013
NCT01834820
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2020

Timeline

NOW
  • Now

Alternative names

Hospital General Naval de Alta Especialidad - Escuela Medico Naval

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Asthma (Phase 4)

Bronchiolitis (Phase 4)

Colic (Phase 3)

Gastroenteritis (Phase 3)

Pancreatitis (Phase 3)

Pneumonia (Phase 2)

Vomiting (Phase 3)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 8
  • # of Trial APIs: 15